TCEAL8抗体TCEAL8兔多抗抗体Transcripti
on elongation factor S-II protein-like 8 antibody抗体TCEAL8 Antibody, Biotin conjugated抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA818261LD01HU
- 2025年07月15日
- ELISA
- Rabbit
- Human
企业认证
相关产品推荐更多 >
NAAA抗体NAAA兔多抗抗体PLT antibody抗体NAAA Antibody抗体
￥440
ZNF177抗体ZNF177兔多抗抗体ZNF177 antibody抗体ZNF177 Antibody抗体
￥440
MRPS28抗体MRPS28兔多抗抗体S35mt antibody抗体MRPS28 Antibody抗体
￥440HPS6抗体HPS6兔多抗抗体Ruby-eye protein homolog antibody抗体HPS6 Antibody抗体
￥440LIPA抗体LIPA兔多抗抗体Sterol esterase antibody抗体LIPA Antibody, Biotin conjugated抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Human Transcription elongation factor A protein-like 8 protein (1-117AA)
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
Polyclonal
- 标记物：
Biotin
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
Q8IYN2
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA
- 浓度：
>95%,Protein G purified
- 靶点：
TCEAL8
- 抗体英文名：
TCEAL8 Antibody, Biotin conjugated
- 抗体名：
TCEAL8 antibody;Transcription elongation factor A protein-like 8 antibody;TCEA-like protein 8 antibody;Transcription elongation factor S-II protein-like 8 antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
功能
May be involved in transcriptional regulation.风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Mapping Protein Distributions on Polytene Chromosomes by Immunostaining
secondary antibody. For double-labeling experiments, use fluorescence-conjugated secondary antibodies raised to the corresponding type of primary antibody. The dilution factor for each antibody needs to be determined experimentally. Blocking
cells. The catalytic domain of diphtheria toxin catalyzes the NAD+ -dependent ADP-ribosylation of the diphthamide residue in elongation factor 2, resulting in inhibition of protein synthesis (20 ,21 ). As the delivery of a single molecule
【翻译】Development trends for monoclonal antibody cancer therapeutics
has more than tripled since the 1980s, from 4.3 per year in the 1980s to 8.3 per year in the 1990s and 13.3 per year for 2000–2005. One reason for the increased investment in mAbs was the evolution of the discovery technology. The initial method for producing mAbs
技术资料暂无技术资料 索取技术资料
